Epithelin/granulin growth factors: Extracellular cofactors for HIV-1 and HIV-2 Tat proteins

被引:27
|
作者
Trinh, DP
Brown, KM
Jeang, KT
机构
[1] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA
[2] NIAID, Mol Microbiol Lab, Mol Virol Sect, NIH, Bethesda, MD 20892 USA
关键词
HIV-1; HIV-2; Tat protein; protein binding; epithelin; granulin;
D O I
10.1006/bbrc.1999.0317
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelin/granulin growth factor is synthesized as a 593 amino acid precursor protein that contains 7.5 imperfectly conserved repeats of approximately 57 amino acids. Processed epithelin/granulin peptides have been isolated from vertebrate/invertebrate species and are growth factors implicated in epithelial and haemic cell function. Here they are identified as Human Immunodeficiency Virus (HIV) Tat binding proteins using the yeast two-hybrid assay. Intracellularly in yeast, mutation of selected cysteines in an epithelin/granulin dimeric repeat caused loss of binding to Tat exon 1. In vitro binding of HIV-1 and HIV-2 Tat to epithelin/granulin dimeric and monomeric repeats was also observed by GST-glutathione bead "pulldown" assays. Because Tat is actively secreted from HIV-infected cells and has been shown to serve as a mitogenic factor for angiogenesis and for Kaposi-like cells, our observations suggest that epithelin/granulin growth factors may function as biologically important extracellular Tat co-factors. (C) 1999 Academic Press.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 50 条
  • [41] SEROLOGICAL DISCRIMINATION BETWEEN HIV-1 AND HIV-2
    SCHULZ, TF
    OBERHUBER, W
    SCHMIDT, B
    GSCHNAIT, F
    HENGSTER, P
    WACHTER, H
    DIERICH, MP
    LANCET, 1988, 2 (8603): : 162 - 163
  • [42] Superinfection of an HIV-2 infected woman by HIV-1
    Huber, M.
    Boeni, J.
    Schuepbach, J.
    Guenthard, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S38 - S38
  • [43] HIV-1 AND HIV-2 COINFECTION OR CROSSED REACTION
    CALDERON, E
    CORZO, JE
    PINEDA, JA
    LEAL, M
    MEDICINA CLINICA, 1990, 94 (11): : 437 - 438
  • [44] TRENDS IN HIV-1 AND HIV-2 INFECTION IN THE GAMBIA
    WILKINS, A
    OELMAN, B
    PEPIN, J
    CHAM, K
    CORRAH, T
    HUGHES, A
    MANNEH, K
    NJAI, R
    ROLFE, M
    SABALLY, S
    WHITTLE, H
    AIDS, 1991, 5 (12) : 1529 - 1530
  • [45] IS HIV-2 LESS PATHOGENIC THAN HIV-1
    MARLINK, R
    KANKI, P
    THIOR, I
    SIBY, T
    MBOUP, S
    ESSEX, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 75 - 76
  • [46] HIV-1 AND HIV-2 DOUBLE INFECTION IN GREECE
    GEORGOULIAS, V
    FOUNTOULI, D
    KARVELAAGELAKIS, A
    KOMIS, G
    MALLIARAKISPINETIDOU, E
    ANTONIADIS, G
    SAMAKIDIS, K
    KONDAKIS, X
    PAPAPETROPOULOU, M
    ZOUMBOS, N
    AXENIDOU, O
    MAKRIS, K
    SONIDIS, G
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (01) : 155 - 155
  • [47] Protection from HIV-1 infection by HIV-2
    Travers, KU
    Eisen, GE
    Marlink, RG
    Essex, ME
    Hsieh, CC
    Mboup, S
    Kanki, PJ
    AIDS, 1998, 12 (02) : 224 - 225
  • [48] Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat
    Rusnati, M
    Urbinati, C
    Caputo, A
    Possati, L
    Lortat-Jacob, H
    Giacca, M
    Ribatti, D
    Presta, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22420 - 22425
  • [49] Multispot™ HIV-1/HIV-2 rapid test
    O'Connell, Robert J.
    Peel, Sheila A.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (05) : 499 - 505
  • [50] QUANTITATIVE INFECTIVITY ASSAY FOR HIV-1 AND HIV-2
    NARA, PL
    FISCHINGER, PJ
    NATURE, 1988, 332 (6163) : 469 - 470